THYROTOXICOSIS IN A PEDIATRIC PATIENT WITH SUPRAVENTRICULAR TACHYCARDIA AND BORDERLINE FEATURES OF THYROID STORM.


Journal

AACE clinical case reports
ISSN: 2376-0605
Titre abrégé: AACE Clin Case Rep
Pays: United States
ID NLM: 101670593

Informations de publication

Date de publication:
Historique:
received: 02 06 2019
accepted: 26 08 2019
entrez: 23 1 2020
pubmed: 23 1 2020
medline: 23 1 2020
Statut: epublish

Résumé

The objective of this report was to emphasize the early recognition of thyrotoxicosis in the assessment of a pediatric patient with tachycardia. We present here the case of a 17-year-old female who presented with supraventricular tachycardia and was found to be in a state of severe thyrotoxicosis with borderline features of a thyroid storm. A 17-year-old African American female presented to the hospital with complaints of nausea, vomiting, and diarrhea associated with palpitations for 1 week. Initial workup included electrocardiogram, total blood count, lipase, basic metabolic panel, and thyroid function tests. Initial vital signs were significant for a temperature of 100.1°F, and tachycardia with a heart rate (HR) of 180 beats per minute (bpm). Initial telemetry was significant for supraventricular tachycardia with a HR of 180 bpm. Vagal maneuvers including carotid sinus massage were attempted first followed by 6 mg intravenous (IV) push and then 12 mg IV push of adenosine. However, the patient remained tachycardic with a HR in the 150s. Laboratory evaluation confirmed the presence of thyrotoxicosis with a thyroid-stimulating hormone of 0.17 μIU/mL (normal, 0.5 to 4.7 μIU/mL) with a free thyroxine of 4.90 ng/dL (normal, 0.8 to 2.0 ng/dL) and free triiodothyronine >20 pg/mL (normal, 1.95 to 5.85 pg/mL). She was subsequently treated with propranolol, methimazole, and hydrocortisone, which resolved her symptoms in a few hours. Due to high mortality rates, severe thyrotoxicosis needs to be recognized and treated early. This case report highlights the importance of early recognition of thyrotoxicosis in the initial management of tachycardia in the pediatric population.

Identifiants

pubmed: 31967079
doi: 10.4158/ACCR-2019-0261
pmc: PMC6873846
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e393-e395

Informations de copyright

Copyright © 2019 AACE.

Déclaration de conflit d'intérêts

DISCLOSURE The authors have no multiplicity of interest to disclose.

Références

Thyroid. 2012 Jul;22(7):661-79
pubmed: 22690898
Ther Adv Endocrinol Metab. 2010 Jun;1(3):139-45
pubmed: 23148158
Thyroid. 2018 Jan;28(1):32-40
pubmed: 28899229
Am Heart J. 1992 Jun;123(6):1543-9
pubmed: 1595533
Arch Med Sci. 2013 Oct 31;9(5):944-52
pubmed: 24273583

Auteurs

Classifications MeSH